Ifrah Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-5,425
Closed -$713K 204
2016
Q2
$713K Sell
5,425
-114
-2% -$15.6K 0.28% 63
2016
Q1
$770K Sell
5,539
-439
-7% -$58.7K 0.31% 63
2015
Q4
$834K Sell
5,978
-215
-3% -$29.6K 0.33% 67
2015
Q3
$867K Sell
6,193
-64
-1% -$9.62K 0.35% 58
2015
Q2
$1.03M Buy
6,257
+1,723
+38% +$275K 0.38% 55
2015
Q1
$700K Sell
4,534
-39
-0.9% -$5.55K 0.26% 74
2014
Q4
$575K Sell
4,573
-216
-5% -$26.7K 0.23% 86
2014
Q3
$573K Sell
4,789
-7
-0.1% -$803 0.22% 81
2014
Q2
$516K Sell
4,796
-58
-1% -$5.98K 0.2% 91
2014
Q1
$483K Sell
4,854
-124
-2% -$11.2K 0.19% 97
2013
Q4
$460K Buy
+4,978
New +$442K 0.18% 101

Other funds holding ELV

Ifrah Financial Services's ELV Position: Q3 2016 in Review

Ifrah Financial Services sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 5,425 shares — an estimated $713K sold.

Ifrah Financial Services first reported a position in ELV in Q4 2013 and held it in 11 quarters. The position peaked at $1.03M in Q2 2015. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

  • Ifrah Financial Services reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
  • Ifrah Financial Services sold 5,425 Elevance Health shares in Q3 2016, an estimated $713K.
  • Ifrah Financial Services first reported a position in Elevance Health in Q4 2013 and held it in 11 quarters.
  • Ifrah Financial Services's Elevance Health position peaked at $1.03M in Q2 2015.
  • 737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Ifrah Financial Services's 13F filing for Q3 2016, filed 7 Nov 2016.